PATH named David C. Kaslow, MD as director of the PATH Malaria Vaccine Initiative (MVI), which “drives the development of safe and effective vaccines for the fight against malaria.” PATH said Dr. Kaslow is a physician-scientist with more than 25 years of vaccine research and development experience, as well as a longstanding interest in the malaria parasite due to both its unique biology and its profound impact on global health. He has held key advisory positions with MVI and the Bill & Melinda Gates Foundation related to malaria vaccines, including—since 2008—serving as chair of MVI’s Vaccine Science Portfolio Advisory Council, the primary external advisory body for MVI. Dr. Kaslow is joining PATH from his position as vice president and head of Vaccines Project Leadership and Management at Merck Research Laboratories (MRL), where his responsibilities have included oversight of project leadership and management of Merck’s vaccine pipeline. http://www.path.org/news/pr120301-mvi-director.php